{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T19:28:17Z","timestamp":1769628497276,"version":"3.49.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1097\/inf.0b013e31819ca49a","type":"journal-article","created":{"date-parts":[[2009,6,26]],"date-time":"2009-06-26T07:22:54Z","timestamp":1246000974000},"page":"619-625","source":"Crossref","is-referenced-by-count":43,"title":["Incidence of Persistent Renal Dysfunction in Human Immunodeficiency Virus-Infected Children"],"prefix":"10.1097","volume":"28","author":[{"given":"Warren A.","family":"Andiman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam C.","family":"Chernoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murli","family":"Purswani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Oleske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paige L.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Spiegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phil","family":"Gona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George R.","family":"Seage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-12-20210202","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1001\/jama.296.3.292","article-title":"Incidence of opportunistic and other infections in HIV-infected children in the HAART era.","volume":"296","author":"Gona","year":"2006","journal-title":"JAMA"},{"key":"R3-12-20210202","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jpeds.2007.11.007","article-title":"Proteinuria in children infected with the human immunodeficiency virus.","volume":"152","author":"Chaparro","year":"2008","journal-title":"J Pediatr"},{"key":"R4-12-20210202","first-page":"396","article-title":"Human immunodeficiency virus (HIV)-associated nephropathy in children from the Washington, DC area: 12 years\u2019 experience.","volume":"18","author":"Ray","year":"1998","journal-title":"Semin Nephrol"},{"key":"R5-12-20210202","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJM198909073211001","article-title":"Renal disease in children with the acquired immunodeficiency syndrome.","volume":"321","author":"Strauss","year":"1989","journal-title":"N Engl J Med"},{"key":"R6-12-20210202","doi-asserted-by":"crossref","first-page":"214","DOI":"10.7326\/0003-4819-139-3-200308050-00011","article-title":"Pathogenesis and treatment of HIV-associated renal diseases: lessons from clinical and animal studies, molecular pathologic correlations, and genetic investigations.","volume":"139","author":"Kimmel","year":"2003","journal-title":"Ann Intern Med"},{"key":"R7-12-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5414\/CNP61001","article-title":"Prevalence of proteinuria and the development of chronic kidney disease in HIV-infected patients.","volume":"61","author":"Gupta","year":"2004","journal-title":"Clin Nephrol"},{"key":"R8-12-20210202","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1086\/320893","article-title":"Renal diseases associated with human immunodeficiency virus infection: epidemiology, clinical course, and management.","volume":"33","author":"Szczech","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R10-12-20210202","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/00000441-200212000-00011","article-title":"Rapid communication: acute renal failure associated with tenofovir: evidence of drug-induced nephrotoxicity.","volume":"324","author":"Coca","year":"2002","journal-title":"Am J Med Sci"},{"key":"R11-12-20210202","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1053\/ajkd.2002.36924","article-title":"Fanconi syndrome and renal failure induced by tenofovir: a first case report.","volume":"40","author":"Verhelst","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"R12-12-20210202","doi-asserted-by":"crossref","first-page":"e711","DOI":"10.1542\/peds.2005-2525","article-title":"Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy: impact on bone mineral density in HIV-infected children.","volume":"118","author":"Gafni","year":"2006","journal-title":"Pediatrics"},{"key":"R13-12-20210202","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/INF.0b013e3181256570","article-title":"Increased beta-2 microglobulinuria in human immunodeficiency virus-1-infected children and adolescents treated with tenofovir.","volume":"26","author":"Papaleo","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R14-12-20210202","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1086\/524061","article-title":"Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy.","volume":"197","author":"Goicoechea","year":"2008","journal-title":"J Infect Dis"},{"key":"R15-12-20210202","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00041552-200009000-00003","article-title":"Renal toxicity of protease inhibitors.","volume":"9","author":"Olyaei","year":"2000","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R16-12-20210202","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1007\/s00467-006-0109-3","article-title":"Nephrotoxicity in a child with perinatal HIV on tenofovir, didanosine and lopinavir\/ritonavir.","volume":"21","author":"Hussain","year":"2006","journal-title":"Pediatr Nephrol"},{"key":"R17-12-20210202","first-page":"1042","article-title":"The Harriet Lane Handbook: A Manual for Pediatric House Officers. 15 ed.","year":"2000"},{"key":"R18-12-20210202","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1542\/peds.58.2.259","article-title":"A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine.","volume":"58","author":"Schwartz","year":"1976","journal-title":"Pediatrics"},{"key":"R19-12-20210202","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1086\/430257","article-title":"Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America.","volume":"40","author":"Gupta","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R20-12-20210202","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression Models and Life-Tables.","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc Ser B (Methodological)"},{"key":"R21-12-20210202","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4899-3115-3","article-title":"Modelling Survival Data in Medical Research.","author":"Collett","year":"1994"},{"key":"R22-12-20210202","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF01066064","article-title":"A comparison of numerical integrating algorithms by trapezoidal, Lagrange, and spline approximation.","volume":"6","author":"Yeh","year":"1978","journal-title":"J Pharmacokinet Biopharm"},{"key":"R24-12-20210202","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1086\/318493","article-title":"Resolution of organ-specific complications of human immunodeficiency virus infection in children with use of highly active antiretroviral therapy.","volume":"32","author":"Saulsbury","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R25-12-20210202","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00000441-200202000-00009","article-title":"Observations on HIV-associated renal disease in the era of highly active antiretroviral therapy.","volume":"323","author":"Cosgrove","year":"2002","journal-title":"Am J Med Sci"},{"key":"R26-12-20210202","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/QAD.0b013e3282f4706d","article-title":"Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease.","volume":"22","author":"Kalayjian","year":"2008","journal-title":"AIDS"},{"key":"R27-12-20210202","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1086\/529385","article-title":"Predictors of renal outcome in HIV-associated nephropathy.","volume":"46","author":"Post","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R28-12-20210202","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0140-6736(98)24037-2","article-title":"HIV-1-associated nephropathy and response to highly-active antiretroviral therapy.","volume":"352","author":"Wali","year":"1998","journal-title":"Lancet"},{"key":"R29-12-20210202","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0272-6386(99)70352-5","article-title":"Familial clustering of end-stage renal disease in blacks with HIV-associated nephropathy.","volume":"34","author":"Freedman","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"R30-12-20210202","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1046\/j.1523-1755.63.s83.10.x","article-title":"HIV-associated nephropathy in African Americans.","author":"Kopp","year":"2003","journal-title":"Kidney Int Suppl"},{"key":"R31-12-20210202","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00000441-200202000-00002","article-title":"The epidemiology of end-stage renal disease among African Americans.","volume":"323","author":"Martins","year":"2002","journal-title":"Am J Med Sci"},{"key":"R32-12-20210202","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1086\/587994","article-title":"Chronic kidney disease incidence, and progression to end-stage renal disease, in hiv-infected individuals: a tale of two races.","volume":"197","author":"Lucas","year":"2008","journal-title":"J Infect Dis"},{"key":"R33-12-20210202","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/0272-6386(95)90490-5","article-title":"Pattern of glomerular involvement in human immunodeficiency virus-infected patients: an Italian study.","volume":"26","author":"Casanova","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"R34-12-20210202","first-page":"627","article-title":"HIV-associated renal disease in London hospitals.","volume":"88","author":"Connolly","year":"1995","journal-title":"QJM"},{"key":"R35-12-20210202","first-page":"161","article-title":"Prevalence of chronic kidney disease and associated risk factors-United States, 1999\u20132004.","author":"Saydah","year":"2007","journal-title":"Morb Mortal Wkly Rep"},{"key":"R36-12-20210202","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1681\/ASN.V11112079","article-title":"Renal epithelium is a previously unrecognized site of HIV-1 infection.","volume":"11","author":"Bruggeman","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"R37-12-20210202","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1681\/ASN.V81138","article-title":"HIV infection and the kidney.","volume":"8","author":"D\u2019Agati","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"R38-12-20210202","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1681\/ASN.V12122645","article-title":"Microcyst formation and HIV-1 gene expression occur in multiple nephron segments in HIV-associated nephropathy.","volume":"12","author":"Ross","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"R39-12-20210202","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1086\/505497","article-title":"HIV type 1 RNA level as a clinical indicator of renal pathology in HIV-infected patients.","volume":"43","author":"Estrella","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R40-12-20210202","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1056\/NEJMc051607","article-title":"Viral load and HIV-associated nephropathy.","volume":"353","author":"Izzedine","year":"2005","journal-title":"N Engl J Med"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006454-200907000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T11:14:15Z","timestamp":1739186055000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-200907000-00012"}},"subtitle":["Associations With the Use of Antiretrovirals, and Other Nephrotoxic Medications and Risk Factors"],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e31819ca49a","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}